Veeva Systems Inc - Class A
Research Veeva Systems Inc - Class A (VEEV) on Bullrun: valuation model: 17.3% overvalued, market cap USD 47.92B, P/E 48.7. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVEEV
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyUSD
- Valuation signal17.3% overvalued
- Market capUSD 47.92B
- P/E48.7
- Financial periodFY2026
- RevenueUSD 3.20B
- Revenue growth16.3%
- Net incomeUSD 908.91M
- Free cash flowUSD 1.42B
- Gross margin75.5%
Valuation Snapshot
Bullrun's latest valuation model marks Veeva Systems Inc - Class A as 17.3% overvalued; latest market cap is USD 47.92B; P/E is 48.7.
Peer valuation comparison
Latest P/E is 48.72x versus a Healthcare sector median of 24.61x (98.0% above).
Latest P/E is 48.72x versus a United States median of 23.85x (104.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 3.20B | USD 908.91M | USD 1.42B | 75.5% | 5.44 | USD 1.42B | USD 95.86M | USD 7.21B |
| FY2025 | USD 2.75B | USD 714.14M | USD 1.09B | 74.5% | 4.32 | USD 1.12B | USD 75.78M | USD 5.83B |
| FY2024 | USD 2.36B | USD 525.71M | USD 911.34M | 71.3% | 3.22 | USD 703.49M | USD 55.78M | USD 4.64B |
| FY2023 | USD 2.16B | USD 487.71M | USD 780.47M | 71.7% | 3 | USD 886.47M | USD 60.98M | USD 3.72B |
| FY2022 | USD 1.85B | USD 427.39M | USD 764.46M | 72.8% | 2.63 | USD 1.14B | USD 54.59M | USD 2.91B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 47.92B | 48.7 | n/a | n/a |
| 2025 | 2025-12-31 | USD 36.69B | 43.3 | n/a | n/a |
| 2024 | 2024-12-31 | USD 34.13B | 51.9 | n/a | n/a |
| 2023 | 2023-12-29 | USD 31.00B | 55.3 | n/a | n/a |
| 2022 | 2022-12-30 | USD 25.13B | 66.1 | n/a | n/a |
| 2021 | 2021-12-31 | USD 39.28B | 95.7 | n/a | n/a |
About Veeva Systems Inc - Class A
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution;
ETFs that hold Veeva Systems Inc - Class A
Veeva Systems Inc - Class A is one of the ten largest holdings of 13 ETFs that investors in Europe can buy. The 8 most traded of them:
| ETF | Weight | TER |
|---|---|---|
| Xtrackers S&P 500 Equal Weight UCITS ETF 1C | 0.33% | 0.15% |
| WisdomTree Cloud Computing UCITS ETF - USD Acc | 1.78% | 0.40% |
| VanEck Morningstar US ESG Wide Moat UCITS ETF | 3.61% | 0.49% |
| Xtrackers S&P 500 Equal Weight UCITS ETF 2C EUR Hedged | 0.33% | 0.30% |
| Xtrackers S&P 500 Equal Weight UCITS ETF 2D | 0.33% | 0.15% |
| iShares MSCI World Mid-Cap Equal Weight UCITS ETF | 0.24% | 0.30% |
| Invesco S&P 500 Equal Weight Index ETF Inc | 0.33% | 0.20% |
| Xtrackers S&P 500 Equal Weight UCITS ETF 1D GBP Hedged | 0.33% | 0.17% |
Compare every fund on the same index:
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Veeva Systems Inc - Class A overvalued or undervalued?
Bullrun's valuation model currently marks Veeva Systems Inc - Class A as 17.3% overvalued.
What is Veeva Systems Inc - Class A's market cap?
Veeva Systems Inc - Class A's market capitalization is USD 47.92B.
What is Veeva Systems Inc - Class A's P/E ratio?
Veeva Systems Inc - Class A's price-to-earnings (P/E) ratio is 48.7.
What does Veeva Systems Inc - Class A do?
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands.